Digital therapeutics are demonstrating meaningful improvement in patient control of diabetes. This session explores the evolving landscape of diabetes digital therapeutics and how state Medicaid programs have initiated programs to enhance access to devices such as continuous glucose monitors (CGM). Representatives from Texas and Kentucky State Medicaid Managed Care Organizations (MCO), and health care providers will discuss their experiences, policy changes, and collaborative efforts to improve CGM utilization and patient outcomes.

Attendees will gain valuable insights into the factors driving changes to CGM coverage policies and best practices, and the collaborative efforts of payers, Medicaid enrollees and health care providers to enhance CGM access and utilization for better patient clinical outcomes.

Made possible through the generous support of our Diamond Sponsor: